July 3 (Reuters) - Sirtex Medical (SRX) said on Tuesday Australia's foreign investment regulator had approved its $1.4 billion buyout by a Chinese consortium.
The company had agreed last month to an offer from Beijing-based CDH Investments and its partner, China Grand Pharmaceutical and Healthcare Holdings 0512.HK , which trumped a bid from U.S.-based Varian Medical Systems VAR.N .
July 3 (Reuters) - Sirtex Medical (SRX) said on Tuesday...
Add to My Watchlist
What is My Watchlist?